Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection

Travis E. Grotz,Michael J. Overman,Cathy Eng,Kanwal Pratap Singh Raghav,Richard E. Royal,Paul F. Mansfield,Gary N Mann,Kristen Ashlee Robinson,Karen A. Beaty,Safia Rafeeq,Aurelio Matamoros,Melissa W. Taggart,Keith Francis Fournier

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection

2017

Travis E. Grotz
Michael J. Overman
Cathy Eng
Kanwal Pratap Singh Raghav
Richard E. Royal
Paul F. Mansfield
Gary N Mann
Kristen Ashlee Robinson
Karen A. Beaty
Safia Rafeeq
Aurelio Matamoros
Melissa W. Taggart
Keith Francis Fournier

Background Moderately and poorly differentiated adenocarcinoma of the appendix represents an aggressive histological variant with a high risk of recurrence and death.

Keywords:

General surgery
Hyperthermic intraperitoneal chemotherapy
Appendix
Oncology
Appendiceal Adenocarcinoma
Surgery
Internal medicine
Medicine
Adenocarcinoma
poorly differentiated
cytoreductive surgery
Surgical oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations